Matthew Stuart McKinney, MD
Cellular Therapy Specialist, Hematologic Oncologist, Hematologist (Malignant)
My Locations
Part of the Duke Cancer Institute
Part of the Duke Cancer Institute
About Me
I treat adult patients who have hematologic malignancies with a focus on lymphomas. I enjoy seeing a variety of different people from different walks of life. Most of the patients I see have a lymphoma diagnosis. Some examples of lymphomas we see are diffuse large B-cell lymphoma, Hodgkin’s lymphoma, mantle cell lymphoma, follicular lymphoma, as well as T-cell lymphoma. The first thing when I meet a patient is to get to know them and their family the best that I can. When I see patients, my goal is that they receive the best care that is available to them anywhere.
- Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy 2024
- Member of the Duke Cancer Institute, Duke Cancer Institute 2023
Call for an Appointment
Areas of Expertise
- Lymphoma
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Small and Large Intestine Disorders
- Waldenstrom's Macroglobulinemia
- Cutaneous Lymphoma
- CAR T-Cell Therapy
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
In the News
Loading
Clinical Focus and Research
-
MB-CART2019.1 DLBCL (Diffuse Large B Cell Lymphoma)IRB# PRO00105486 , NCT# NCT04792489
-
A052101: Mantle Cell LymphomaIRB# PRO00114717 , NCT# NCT05976763
-
S2114: Therapy Following CAR-T (Diffuse Large B-cell Lymphoma or Grade IIIB Follicular Lymphoma)IRB# PRO00114793 , NCT# NCT05633615
-
Schrödi:Ph1 dose escalation of SGR-1505 as monotherapy in subject with mature B-cell malignanciesIRB# PRO00113371 , NCT# NCT05544019
- INCB50465-801 Rollover (7008420 awarded by Incyte Corporation 2023 - 2028
- Strickler, J. H., and M. S. McKinney. Preface, 2022. https://doi.org/10.1016/B978-0-12-800684-9.00007-1.
- Ginsburg, G. S., H. F. Willard, J. H. Strickler, and M. S. McKinney. Genomic and Precision Medicine: Oncology, Third Edition, 2022. https://doi.org/10.1016/C2015-0-06901-5.
- McKinney, M. J., and S. Johnson. Working Across Boundaries: People, Nature, and Regions, 2009.
- Kumar, Anivarya, Jennifer R. Owen, Nicholette T. Sloat, Elizabeth Maynard, Vanessa M. Hill, Christopher B. Hubbard, Matthew S. McKinney, et al. “Expansion of an Academic Molecular Tumor Board to Enhance Access to Biomarker-Driven Trials and Therapies in the Rural Southeastern United States.” Current Oncology (Toronto, Ont.) 31, no. 11 (November 2024): 7244–57. https://doi.org/10.3390/curroncol31110534.
- Lin, Chenyu, Katherine I. Zhou, Michelle F. Green, Bennett A. Caughey, John H. Strickler, Michael B. Datto, and Matthew S. McKinney. “Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice.” Hematol Rep 16, no. 4 (September 30, 2024): 603–11. https://doi.org/10.3390/hematolrep16040059.
- Wierda, William G., Nirav N. Shah, Chan Y. Cheah, David Lewis, Marc S. Hoffmann, Catherine C. Coombs, Nicole Lamanna, et al. “Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study.” Lancet Haematol 11, no. 9 (September 2024): e682–92. https://doi.org/10.1016/S2352-3026(24)00172-8.
- McKinney, M. S., and J. H. Strickler. “Introduction and overview of cancer precision medicine.” In Genomic and Precision Medicine: Oncology, Third Edition, 1–11, 2022. https://doi.org/10.1016/B978-0-12-800684-9.00008-3.
- McKinney, M. S., and S. S. Dave. “Origin of Non-Hodgkin Lymphoma and Therapeutic Targets.” In Hematology: Basic Principles and Practice, Eighth Edition, 1352–66, 2022. https://doi.org/10.1016/B978-0-323-73388-5.00081-X.
- Jauhari, S., and M. McKinney. “Hepatosplenic T-cell lymphoma.” In Novel Therapeutics for Rare Lymphomas, 209–20, 2019. https://doi.org/10.1007/978-3-030-25610-4_13.
- Lewis, David John, M Lia Palomba, Manish R. Patel, Toby A. Eyre, Wojciech Jurczak, Thomas Gastinne, Shuo Ma, et al. “Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia.” In BRITISH JOURNAL OF HAEMATOLOGY, 201:109–10, 2023.
- Wang, Xiaobei, Parker Mathews, Krista Rowe Nichols, Shaima Jabbar, Johanna Jensen, Jonathan Huggis, Daniel Schrum, et al. “Comprehensive myeloid-derived suppressor cell (MDSC) immunophenotyping and functional assessment in chimeric antigen receptor (CAR) T therapy.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
- Soliman, Dina, Veronica Russell, Kikkeri Naresh, Sarah Ondrejka, Eric Hsi, Jean Koff, Einas Al Kuwari, et al. “Genomic Characterization of Mycosis Fungoides Identifies a Genomic Subset Associated with Large Cell Phenotype and Poor Survival.” In LABORATORY INVESTIGATION, 103:S1239–40, 2023.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- ADC therapeutics
- BeiGene
- Incyte
- Roche/Genentech